Tag: BIO

Lynk Pharmaceuticals’ Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor

HANGZHOU, China, SHANGHAI and BOSTON, June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on...

Tevogen Announces Formation of a Healthcare Services Initiative

Tevogen launches Healthcare Services initiative to evaluate MSO and CRO acquisitions with potential to support approximately $100M in annual revenue.

Albert Einstein College of Medicine Launches BIO-VITAL to Accelerate Gerotherapeutics

New Program Connects Biotech and Pharmaceutical Partners with Einstein's Aging Research Expertise and Scientific Infrastructure BRONX, N.Y., June 9, 2026 /PRNewswire/ -- Albert Einstein...

MDP Enters OLIVE YOUNG

MDP launched four key SKUs at OLIVE YOUNG Pasadena, which opened on May 29. Additional rollout planned for the upcoming OLIVE YOUNG Century City...

CAREstream America introduces new era of science-backed innovation to deliver a new standard of quality to the US aesthetic market

CAREstream America announces an exclusive distribution partnership to bring Celltermi HS and NX Plus, an advanced probiotic-derived microbiome technology, to the US market. Celltermi...

Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions

Post hoc analyses explored the impact of semaglutide across an array of conditions including obstructive sleep apnea (OSA), asthma-related adverse outcomes, liver health, cardiometabolic...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsBIO

HKC, ANTGAMER, KOORUI Make Strong Debut at COMPUTEX 2026 with World-First Display Innovations

High Arctic Announces Management Changes

NeuroRester Launches Wearable 2.0: An Ecosystem Designed to Move Beyond Tracking with Proprietary NAP™ Technology

Tag: BIO

Lynk Pharmaceuticals’ Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor

Tevogen Announces Formation of a Healthcare Services Initiative

Albert Einstein College of Medicine Launches BIO-VITAL to Accelerate Gerotherapeutics

MDP Enters OLIVE YOUNG

CAREstream America introduces new era of science-backed innovation to deliver a new standard of quality to the US aesthetic market

Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us